UBS Group’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$960M Buy
4,841,336
+2,164,229
+81% +$504M 0.14% 137
2025
Q4
$718M Sell
2,677,107
-1,689,536
-39% -$429M 0.12% 161
2025
Q3
$1.08B Buy
4,366,643
+183,520
+4% +$47.9M 0.17% 97
2025
Q2
$1.25B Buy
4,183,123
+1,380,530
+49% +$420M 0.22% 77
2025
Q1
$875M Sell
2,802,593
-148,861
-5% -$52.6M 0.16% 111
2024
Q4
$1.04B Buy
2,951,454
+89,187
+3% +$32.1M 0.19% 92
2024
Q3
$1.01B Sell
2,862,267
-361,602
-11% -$119M 0.22% 83
2024
Q2
$978M Sell
3,223,869
-205,722
-6% -$63M 0.24% 75
2024
Q1
$1.19B Buy
3,429,591
+232,555
+7% +$84.8M 0.3% 51
2023
Q4
$1.12B Buy
3,197,036
+264,053
+9% +$85.1M 0.34% 50
2023
Q3
$901M Buy
2,932,983
+159,392
+6% +$50.2M 0.31% 56
2023
Q2
$856M Buy
2,773,591
+188,341
+7% +$54.7M 0.29% 74
2023
Q1
$739M Buy
2,585,250
+58,757
+2% +$16M 0.27% 74
2022
Q4
$674M Buy
2,526,493
+227,790
+10% +$63M 0.25% 78
2022
Q3
$591M Sell
2,298,703
-143,851
-6% -$41.6M 0.26% 78
2022
Q2
$678M Sell
2,442,554
-1,176,890
-33% -$354M 0.28% 75
2022
Q1
$1.22B Sell
3,619,444
-459,705
-11% -$155M 0.41% 43
2021
Q4
$1.69B Sell
4,079,149
-296,645
-7% -$108M 0.48% 28
2021
Q3
$1.4B Sell
4,375,794
-528,937
-11% -$172M 0.44% 33
2021
Q2
$1.45B Sell
4,904,731
-135,167
-3% -$38.7M 0.47% 31
2021
Q1
$1.39B Sell
5,039,898
-458,460
-8% -$119M 0.46% 30
2020
Q4
$1.44B Sell
5,498,358
-145,636
-3% -$34.9M 0.49% 30
2020
Q3
$1.28B Buy
5,643,994
+548,297
+11% +$126M 0.48% 36
2020
Q2
$1.09B Sell
5,095,697
-826,861
-14% -$156M 0.46% 40
2020
Q1
$967M Sell
5,922,558
-942,354
-14% -$182M 0.46% 43
2019
Q4
$1.45B Sell
6,864,912
-215,098
-3% -$41.9M 0.5% 32
2019
Q3
$1.36B Sell
7,080,010
-1,425,773
-17% -$276M 0.52% 31
2019
Q2
$1.57B Buy
8,505,783
+340,621
+4% +$61.2M 0.61% 26
2019
Q1
$1.44B Buy
8,165,162
+556,877
+7% +$87.5M 0.59% 26
2018
Q4
$1.07B Sell
7,608,285
-271,406
-3% -$42.9M 0.49% 36
2018
Q3
$1.34B Buy
7,879,691
+498,305
+7% +$82.9M 0.53% 27
2018
Q2
$1.21B Buy
7,381,386
+275,507
+4% +$42.9M 0.52% 28
2018
Q1
$1.09B Buy
7,105,879
+278,638
+4% +$44.1M 0.47% 33
2017
Q4
$1.05B Buy
6,827,241
+328,355
+5% +$47.6M 0.43% 33
2017
Q3
$878M Buy
6,498,886
+469,325
+8% +$61.1M 0.41% 39
2017
Q2
$746M Buy
6,029,561
+397,791
+7% +$48.5M 0.39% 53
2017
Q1
$675M Buy
5,631,770
+279,058
+5% +$33.3M 0.37% 51
2016
Q4
$627M Buy
5,352,712
+188,153
+4% +$22.3M 0.35% 51
2016
Q3
$631M Buy
5,164,559
+486,906
+10% +$55.4M 0.38% 44
2016
Q2
$530M Buy
4,677,653
+268,431
+6% +$31.1M 0.33% 52
2016
Q1
$509M Buy
4,409,222
+833,959
+23% +$85.7M 0.34% 49
2015
Q4
$374M Buy
3,575,263
+3,171,348
+785% +$335M 0.24% 84
2015
Q3
$39.7M Buy
403,915
+22,058
+6% +$2.19M 0.03% 554
2015
Q2
$37M Sell
381,857
-31,522
-8% -$3.01M 0.02% 641
2015
Q1
$38.7M Sell
413,379
-286,115
-41% -$25.5M 0.03% 611
2014
Q4
$62.5M Buy
+699,494
New +$58.1M 0.04% 448

Other funds holding ACN

UBS Group's ACN Position: Q1 2026 in Review

UBS Group increased its Accenture (ACN) stake by 81% in Q1 2026, buying an estimated $504M and bringing the position to 4,841,336 shares worth $960M. The position accounts for 0.14% of the portfolio, ranked #137.

UBS Group first reported a position in ACN in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.69B in Q4 2021. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • UBS Group held 4,841,336 shares of Accenture worth $960M as of Q1 2026.
  • UBS Group bought 2,164,229 Accenture shares in Q1 2026, an estimated $504M.
  • Accenture made up 0.14% of UBS Group's portfolio in Q1 2026, its #137 holding.
  • UBS Group first reported a position in Accenture in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Accenture position peaked at $1.69B in Q4 2021.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.